D. Wood

发表

Characterization of formaldehyde-inactivated poliovirus preparations made from live-attenuated strains.

Javier Martin, P. Minor, Graham Crossland, 2003, The Journal of general virology.

Mitochondrial DNA and retroviral RNA analyses of archival oral polio vaccine (OPV CHAT) materials: evidence of macaque nuclear sequences confirms substrate identity.

G. Schild, Javier Martin, P. Minor, 2005, Vaccine.

Vaccine safety: Analysis of oral polio vaccine CHAT stocks

G. Schild, P. Minor, D. Wood, 2001, Nature.

A novel cytopathic microtitre plate assay for hepatitis A virus and anti-hepatitis A neutralizing antibodies.

J. Saldanha, P. Minor, L. Beales, 1996, Journal of virological methods.

Detection, typing, and subtyping of enteric adenoviruses 40 and 41 from fecal samples and observation of changing incidences of infections with these types and subtypes

A. Osterhaus, J. D. de Jong, H. G. van der Avoort, 1993, Journal of clinical microbiology.

Examination of poliovirus vaccine preparations for SV40 sequences.

P. Minor, D. Sangar, D. Wood, 1999, Biologicals : journal of the International Association of Biological Standardization.

Heterogeneity of genome rearrangements in rotaviruses isolated from a chronically infected immunodeficient child

G. Beards, U. Desselberger, D. Wood, 1987, Journal of virology.

Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.

R. Linkins, P. Minor, D. Magrath, 1995, Bulletin of the World Health Organization.

One‐year prospective cross‐sectional study to assess the importance of group F adenovirus infections in children under 2 years admitted to hospital

D. Wood, R. Killough, T. David, 1988, Journal of medical virology.

Characterisation of Chlamydia psittaci isolated from a horse.

D. Wood, T. Mair, M. Lusher, 1990, Veterinary microbiology.

The scientific basis for stopping polio immunisation--issues and challenges.

D. Wood, 2001, Developments in biologicals.

Comparative study of five methods for intratypic differentiation of polioviruses

M. Pallansch, M. Mulders, O. Kew, 1995, Journal of clinical microbiology.

Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man

D. Pillay, R. Thompson, C. MacLennan, 2004, The Lancet.

L20B cells simplify culture of polioviruses from clinical samples

D. Wood, B. Hull, 1999, Journal of medical virology.

Antigenic structure of poliovirus in inactivated vaccines.

P. Minor, M. Ferguson, D. Wood, 1993, The Journal of general virology.

A WHO collaborative study of immunogenicity assays of inactivated poliovirus vaccines.

A. Heath, D. Wood, 1995, Biologicals : journal of the International Association of Biological Standardization.

Potency of wild-type or sabin trivalent inactivated poliovirus vaccine, by enzyme-linked immunosorbent assay using monoclonal antibiotics specific for each antigenic site.

E. C. Beuvery, L. Sawyer, R. Crainic, 1997, Biologicals : journal of the International Association of Biological Standardization.

Detection of adenovirus types 40 and 41 in stool specimens by immune electron microscopy

D. Wood, A. Bailey, 1987, Journal of medical virology.

Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine.

A. Barrett, E. Wang, P. Minor, 1995, The Journal of general virology.

Antigenic structure of chimeras of type 1 and type 3 polioviruses involving antigenic sites 2, 3 and 4.

G. Dunn, P. Minor, J. Almond, 1991, The Journal of general virology.

Antigenic structure of chimeras of type 1 and type 3 poliovirus involving antigenic site 1.

G. Dunn, P. Minor, J. Almond, 1990, The Journal of general virology.

A new WHO International Reference Reagent for use in potency assays of inactivated poliomyelitis vaccine.

E. C. Beuvery, A. Heath, G. Kersten, 1997, Biologicals : journal of the International Association of Biological Standardization.

A WHO Collaborative study on assays of the antigenic content of inactivated poliovirus vaccines.

L. Sawyer, A. Heath, D. Wood, 1995, Biologicals : journal of the International Association of Biological Standardization.

Comparability of poliovirus neutralizing antibody tests.

A. Heath, D. Wood, 1992, Biologicals : journal of the International Association of Biological Standardization.

The Second International Standard for anti-poliovirus sera types 1, 2 and 3.

A. Heath, D. Wood, 1992, Biologicals : journal of the International Association of Biological Standardization.

Adenovirus gastroenteritis

D. Wood, 1988, British medical journal.

Development and evaluation of monoclonal antibody-based immune electron microscopy for diagnosis of adenovirus types 40 and 41.

J. D. de Jong, H. G. van der Avoort, D. Wood, 1989, Journal of virological methods.

Guidelines on stability evaluation of vaccines.

T. Schofield, I. Susanti, M. Pfleiderer, 2009, Biologicals : journal of the International Association of Biological Standardization.

Viral infections in childhood leukemia.

D. Wood, G. Corbitt, 1985, The Journal of infectious diseases.

Biophysical characterization of rotavirus particles containing rearranged genomes.

U. Desselberger, D. Wood, M. Desselberger, 1987, The Journal of general virology.

Effect of Terminal (Dry) Heat Treatment on Non‐Enveloped Viruses in Coagulation Factor Concentrates

F. Mcomish, A. John, D. Wood, 1994, Vox sanguinis.

Evaluation of a commercial monoclonal antibody-based enzyme immunoassay for detection of adenovirus types 40 and 41 in stool specimens

J. D. de Jong, D. Wood, K. Bijlsma, 1989, Journal of clinical microbiology.

WHO Expert Committee on Biological Standardization: highlights of the 50th meeting, October 1999.

D. Wood, E. Griffiths, A. Padilla, 1999, Biologicals : journal of the International Association of Biological Standardization.

Laboratory diagnosis and clinical significance of rubella in children with cancer

D. Wood, D. Morris, R. Stevens, 1989, Epidemiology and Infection.

Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis.

J. Roehrig, B. Miller, C. J. Mitchell, 1994, The Journal of infectious diseases.

Chronic enteric virus infection in two T‐cell immunodeficient children

D. Wood, T. David, B. Totterdell, 1988, Journal of medical virology.

Characterisation of L cells expressing the human poliovirus receptor for the specific detection of polioviruses in vitro.

P. Minor, V. Racaniello, D. Wood, 1993, Journal of virological methods.

Laboratory tests for live attenuated poliovirus vaccines.

A. Macadam, D. Wood, 1997, Biologicals : journal of the International Association of Biological Standardization.

Australia's last reported case of wild poliovirus infection.

H. Kelly, H. G. van der Avoort, D. Wood, 1999, Communicable diseases intelligence.

Polioviruses: Concurrent Serotyping and lntratypic Differentiation of Polioviruses

D. Wood, 1998 .

Comparative epidemiology of rotavirus, subgenus F (types 40 and 41) adenovirus, and astrovirus gastroenteritis in children

D. Wood, D. Morris, J. Couriel, 1993, Journal of medical virology.

Recent Respiratory and Enteric Adenovirus Infection in Children in the Manchester Area

D. Wood, S. Richmond, A. Bailey, 1988, Journal of the Royal Society of Medicine.

Immunogenicity and antigenicity of chimeric picornaviruses which express hepatitis A virus (HAV) peptide sequences: evidence for a neutralization domain near the amino terminus of VP1 of HAV.

S. Lemon, W. Barclay, P. Minor, 1992, Virology.

Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates.

S. R. Pollard, R. Skuce, P. Minor, 1993, Virology.

Application of monoclonal antibody panels in the virological and epidemiological review of poliomyelitis in Poland, 1981-1990.

G. Dunn, J. Howlett, A. John, 1992, Bulletin of the World Health Organization.

Stopping poliovirus vaccination after eradication: issues and challenges.

W. Dowdle, R. Sutter, D. Wood, 2000, Bulletin of the World Health Organization.

New approaches to oral poliovirus vaccine neurovirulence tests: transgenic mice susceptible to poliovirus and molecular analysis of poliovirus. A meeting report of the WHO Global Programme for Vaccines and Immunization and the WHO Biologicals Unit, Geneva, Switzerland, 26-28 September 1996.

D. Wood, 1997, Vaccine.

Re: Laboratory tests for live attenuated poliovirus vaccine. Subhash C. Arya; Biologicals, Volume 26, pp. 245-246, 1998.

J. Milstien, D. Wood, M. Zaffran, 1999, Biologicals : journal of the International Association of Biological Standardization.

Dental Mitigation Strategies to Reduce Aerosolization of SARS-CoV-2

D. Wood, D. Devine, D. Wood, 2021, medRxiv.

The vaccine origin of the 1968 epidemic of type 3 poliomyelitis in Poland.

Javier Martin, P. Minor, G. Ferguson, 2000, Virology.

Rat bioassay for inactivated poliomyelitis vaccine COLLABORATIVE STUDY FOR THE ESTABLISHMENT OF A RAT BIOASSAY FOR INACTIVATED POLIOMYELITIS VACCINE Project leader :

A. Heath, D. Wood, 2012 .

Use of human diploid cells in vaccine production.

P. Minor, D. Wood, D J Wood, 1990, Biologicals : journal of the International Association of Biological Standardization.

The Molecular Repertoire of Adenoviruses III Biology and Pathogenesis: Edited by W. Doerfler and P. Bohm. 1995. ISBN 3-540-58987-2. Pp. 310. DM 198.00 (Hardback).

D. Wood, 1997 .

Transgenic mice as an alternative to monkeys for neurovirulence testing of live oral poliovirus vaccine: validation by a WHO collaborative study.

Takeshi Kurata, Tatsuji Nomura, A. Heath, 2003, Bulletin of the World Health Organization.

Use of FITC-protein A in place of fluorescein-conjugated anti-gammaglobulins for rapid virus diagnosis by immunofluorescence.

D. Wood, G. Corbitt, 1982, Journal of clinical pathology.